People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alleviant Medical, Inc. | — | Healthtech | Series C | $148.8M | $677.4M | 2017 |
Christopher Alex Arevalos at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Alex Arevalos on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian R. Smith | 1 | 21 |
| Kirk Nielsen | 1 | 13 |
| Ashok Gowda | 1 | 12 |
| Christopher Kaster | 1 | 5 |
| Geoff R. Pardo | 1 | 4 |
| Adam Berman | 1 | 4 |
| Maria Berkman | 1 | 3 |
| Jay R Schmelter | 1 | 2 |
| Jacob Kriegel | 1 | 1 |
| Avni Alex Patel | 1 | 1 |
| Albertien Alex Greijdanus | 1 | 1 |
| Ian R Meredith | 1 | 1 |
| Maria R Berkman | 1 | 1 |
| Kirk R Nielsen | 1 | 1 |
| Christopher R Kaster | 1 | 1 |
| Gowda R Ashok | 1 | 1 |
| Kirk R Nielson | 1 | 1 |
| Mary Byron | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.